Cutaneous ADRs account for 1030% of ADRs, and are most commonly due to antibiotics
PMCID: PMC7108996 Andersen NB, Malmlf K, Johansen PB, Andreassen TT, rtoft G, Oxlund H
According to the company's website and safety disclosures, you may qualify if: Your Body Mass Index (BMI) is 30 or higher (classified as obese), OR Your BMI is 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, obstructive sleep apnea, or cardiovascular disease, OR Your BMI is above 25 and you may still qualify depending on your overall medical history, as determined by the licensed provider The evaluating clinician reviews your full medical history during intake and makes the final determination about whether treatment is appropriate and safe for your specific situation
This constant support system is designed to prevent the exact dosing errors that lead to hospitalizations
Liraglutide also targets GLP-1 receptors, promoting feelings of fullness and reducing food intake
